Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | ubiquitin specific peptidase 2 | Starlite/ChEMBL | No references |
Homo sapiens | SMAD family member 2 | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Brugia malayi | MH2 domain containing protein | SMAD family member 2 | 467 aa | 405 aa | 31.6 % |
Plasmodium falciparum | ubiquitin specific protease, putative | ubiquitin specific peptidase 2 | 362 aa | 378 aa | 25.7 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Schistosoma mansoni | acylaminoacyl-peptidase (S09 family) | 0.0254 | 0.1202 | 0.1202 |
Giardia lamblia | Alanyl dipeptidyl peptidase | 0.0254 | 0.1202 | 1 |
Leishmania major | oligopeptidase B-like protein,serine peptidase, clan SC, family S9A-like protein | 0.0254 | 0.1202 | 0.1217 |
Mycobacterium tuberculosis | Probable protease II PtrBb [second part] (oligopeptidase B) | 0.0254 | 0.1202 | 0.5 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0254 | 0.1202 | 0.1217 |
Echinococcus multilocularis | prolyl endopeptidase | 0.0254 | 0.1202 | 0.1202 |
Toxoplasma gondii | dipeptidyl peptidase iv (dpp iv) n-terminal region domain-containing protein | 0.1076 | 0.5929 | 1 |
Trichomonas vaginalis | Clan SC, family S33, methylesterase-like serine peptidase | 0.0254 | 0.1202 | 1 |
Trypanosoma brucei | oligopeptidase b | 0.0254 | 0.1202 | 0.1217 |
Brugia malayi | prolyl oligopeptidase family protein | 0.0254 | 0.1202 | 0.1202 |
Loa Loa (eye worm) | prolyl oligopeptidase | 0.0254 | 0.1202 | 0.1202 |
Loa Loa (eye worm) | hypothetical protein | 0.0254 | 0.1202 | 0.1202 |
Mycobacterium ulcerans | protease II (oligopeptidase B), PtrB | 0.0254 | 0.1202 | 0.5 |
Leishmania major | dipeptidyl-peptidase 8-like serine peptidase, putative,serine peptidase, Clan SC, Family S9B | 0.1762 | 0.987 | 1 |
Entamoeba histolytica | hypothetical protein, conserved | 0.0254 | 0.1202 | 1 |
Entamoeba histolytica | dipeptidyl-peptidase, putative | 0.0254 | 0.1202 | 1 |
Mycobacterium leprae | PROBABLE PROTEASE II PTRBB (OLIGOPEPTIDASE B) | 0.0254 | 0.1202 | 0.5 |
Brugia malayi | prolyl oligopeptidase family protein | 0.0254 | 0.1202 | 0.1202 |
Loa Loa (eye worm) | MH2 domain-containing protein | 0.0144 | 0.0572 | 0.0572 |
Trypanosoma cruzi | prolyl endopeptidase | 0.0254 | 0.1202 | 0.1217 |
Schistosoma mansoni | prolyl oligopeptidase (S09 family) | 0.0254 | 0.1202 | 0.1202 |
Brugia malayi | hypothetical protein | 0.0822 | 0.4471 | 0.4471 |
Schistosoma mansoni | prolyl oligopeptidase (S09 family) | 0.0254 | 0.1202 | 0.1202 |
Echinococcus granulosus | Dipeptidyl peptidase 9 | 0.1762 | 0.987 | 0.987 |
Brugia malayi | MH2 domain containing protein | 0.0144 | 0.0572 | 0.0572 |
Trypanosoma cruzi | serine peptidase, Clan SC, Family S9B | 0.1762 | 0.987 | 1 |
Echinococcus multilocularis | Dipeptidyl peptidase 9 | 0.1762 | 0.987 | 0.987 |
Brugia malayi | prolyl oligopeptidase family protein | 0.0254 | 0.1202 | 0.1202 |
Trypanosoma brucei | Dipeptidyl-peptidase 8-like, putative | 0.1762 | 0.987 | 1 |
Trypanosoma cruzi | oligopeptidase B-like protein, putative | 0.0254 | 0.1202 | 0.1217 |
Leishmania major | prolyl oligopeptidase, putative,serine peptidase clan SC, family S9A, putative | 0.0254 | 0.1202 | 0.1217 |
Echinococcus multilocularis | acylamino acid releasing enzyme | 0.0254 | 0.1202 | 0.1202 |
Loa Loa (eye worm) | transcription factor SMAD2 | 0.0144 | 0.0572 | 0.0572 |
Entamoeba histolytica | prolyl oligopeptidase family protein | 0.0254 | 0.1202 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0822 | 0.4471 | 0.4471 |
Plasmodium vivax | hypothetical protein, conserved | 0.0254 | 0.1202 | 0.5 |
Entamoeba histolytica | dipeptidyl-peptidase, putative | 0.0254 | 0.1202 | 1 |
Trypanosoma brucei | serine peptidase, Clan SC, Family S9B | 0.1762 | 0.987 | 1 |
Trypanosoma brucei | serine peptidase, clan SC, family S9A-like protein | 0.0254 | 0.1202 | 0.1217 |
Trypanosoma cruzi | oligopeptidase b | 0.0254 | 0.1202 | 0.1217 |
Echinococcus granulosus | acylamino acid releasing enzyme | 0.0254 | 0.1202 | 0.1202 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0254 | 0.1202 | 0.1217 |
Loa Loa (eye worm) | hypothetical protein | 0.0939 | 0.5142 | 0.5142 |
Trichomonas vaginalis | Clan SC, family S9, acylaminoacyl-peptidase-like serine peptidase | 0.0254 | 0.1202 | 1 |
Plasmodium falciparum | peptidase, putative | 0.0254 | 0.1202 | 0.5 |
Trypanosoma brucei | prolyl oligopeptidase, putative | 0.0254 | 0.1202 | 0.1217 |
Brugia malayi | prolyl oligopeptidase family protein | 0.1762 | 0.987 | 0.987 |
Trypanosoma brucei | prolyl endopeptidase | 0.0254 | 0.1202 | 0.1217 |
Entamoeba histolytica | prolyl oligopeptidase family protein | 0.0254 | 0.1202 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0254 | 0.1202 | 1 |
Entamoeba histolytica | prolyl oligopeptidase family protein | 0.0254 | 0.1202 | 1 |
Trypanosoma brucei | Alpha/beta hydrolase domain-containing protein | 0.0254 | 0.1202 | 0.1217 |
Schistosoma mansoni | dipeptidyl-peptidase 9 (S09 family) | 0.1762 | 0.987 | 0.987 |
Leishmania major | oligopeptidase b | 0.0254 | 0.1202 | 0.1217 |
Loa Loa (eye worm) | hypothetical protein | 0.0254 | 0.1202 | 0.1202 |
Echinococcus granulosus | prolyl endopeptidase | 0.0254 | 0.1202 | 0.1202 |
Schistosoma mansoni | prolyl oligopeptidase (S09 family) | 0.0254 | 0.1202 | 0.1202 |
Giardia lamblia | Alanyl dipeptidyl peptidase | 0.0254 | 0.1202 | 1 |
Trypanosoma cruzi | dipeptidyl-peptidase 8-like serine peptidase | 0.1762 | 0.987 | 1 |
Trypanosoma cruzi | serine peptidase, clan SC, family S9A-like protein, putative | 0.0254 | 0.1202 | 0.1217 |
Trypanosoma cruzi | oligopeptidase b | 0.0254 | 0.1202 | 0.1217 |
Mycobacterium tuberculosis | Probable peptidase | 0.0254 | 0.1202 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 0.5858 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | 5.6234 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588856, AID588860] | ChEMBL. | No reference |
Potency (functional) | = 10 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Ubiquitin-specific Protease USP2a. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 31.6228 um | PUBCHEM_BIOASSAY: qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (without detergent). (Class of assay: confirmatory) [Related pubchem assays: 2158 (Confirmation qHTS Assay for Inhibitors of Cruzain), 2249 (Probe Development Summary of Promiscuous Inhibitors (Artifacts) of Cruzain), 2161 (qHTS Assay for Inhibitors of Papain: Counterscreen for Cruzain Assay), 1478 (qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (with detergent))] | ChEMBL. | No reference |
Potency (functional) | 56.2341 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504404] | ChEMBL. | No reference |
Potency (functional) | 100 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Rango (Ran-regulated importin-beta cargo) - Importin beta complex formation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID540273] | ChEMBL. | No reference |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Plasmodium falciparum | ChEMBL23 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.